Страна: Канада
Език: английски
Източник: Health Canada
NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)
APOTEX INC
C07AB12
NEBIVOLOL
5MG
TABLET
NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 5MG
ORAL
100
Prescription
BETA-ADRENERGIC BLOCKING AGENTS
Active ingredient group (AIG) number: 0153531002; AHFS:
APPROVED
2020-12-22
Page 1 of 34 PRODUCT MONOGRAPH PR APO-NEBIVOLOL Nebivolol Tablets 2.5 mg, 5 mg and 20 mg Nebivolol (as nebivolol hydrochloride) Antihypertensive Agent APOTEX INC. Date of Preparation: 150 Signet Drive September 23, 2019 Toronto, Ontario M9L 1T9 Submission Control No: 223530 Page 2 of 34 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ................................................................................. 3 SUMMARY PRODUCT INFORMATION ....................................................................................................... 3 INDICATIONS AND CLINICAL USE ............................................................................................................. 3 CONTRAINDICATIONS .................................................................................................................................. 3 WARNINGS AND PRECAUTIONS ................................................................................................................. 4 ADVERSE REACTIONS .................................................................................................................................. 7 DRUG INTERACTIONS ................................................................................................................................. 11 DOSAGE AND ADMINISTRATION ............................................................................................................. 13 OVERDOSAGE ............................................................................................................................................... 14 ACTION AND CLINICAL PHARMACOLOGY ........................................................................................... 15 STORAGE AND STABILITY......................................................................................................................... 18 SPECIAL HANDLING INSTRUCTIONS ...................................................................................................... 18 DOSAGE FORMS, COMPOSITION AND PACKAGING .. Прочетете целия документ